Seaport presents new meta-analysis examining the impact of clinical trial design factors on placebo response in generalized anxiety disorder trials ...
Male or female outpatients aged 18 to 65 years with a DSM-IV diagnosis of GAD, with a global score ≥21 in the Hamilton Anxiety Rating Scale (HAM-A) and a score <3 points on the 'depressive mood' item ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results